Sign inJoin waitlistJoin the waitlist

RS

Raphael Steiner

Associate Attending Physician · New York Presbyterian Hospital

Credentials: · · · · · · ·

History

Memorial Hospital for Cancer and allied Diseases · Memorial Sloan Kettering Cancer Center
2024–Present

University Hospital Zurich
2019–2021
University Hospital Zurich
2016–2019
UNIV DE LAUSANNE, FAC DE MED, LAUSANNE, SWITZERLAND
2002–2006

Research

A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
Nature Medicine · 2023 · 216 citations
Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma
Blood Advances · 2020 · 198 citations
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma
Blood · 2021 · 193 citations

Sairah Ahmed
41 papers
Ranjit Nair
39 papers
Loretta Nastoupil
37 papers
Paolo Strati
37 papers
Sattva Neelapu
37 papers
Jason Westin
36 papers
Christopher Flowers
32 papers
Swaminathan Iyer
28 papers
Chelsea Pinnix
27 papers
Hun Lee
27 papers
Luis Fayad
25 papers
Bouthaina Dabaja
19 papers

Clinical trials

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
Principal investigator · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2026
Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell Therapy
Principal investigator · Unknown
M.D. Anderson Cancer Center
2020–2025
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
Site PI · Recruiting · Early phase 1
AIDS Malignancy Consortium
2021–2030